Huntsman Cancer Institute leads in robotic cancer surgery with single-port, Ion robotic bronchoscopy and da Vinci 5 systems, enhancing precision, access, and recovery while training surgeons nationwide in advanced techniques.
New research shows regular exercise may change how colon cancer behaves at a molecular level, altering genes in tumors and fat tissue—highlighting the deep impact of movement on health.
The PathMaker program provided Adamaris Martinez with the access, mentorship, and resources she needed to go from a high school student to published author—and now to grad school.
Older adults, rural residents, and others with limited access to care are more likely to be diagnosed late with aggressive skin cancers. Early detection and tailored strategies can improve outcomes.
Huntsman Cancer Institute, alongside the Price College of Engineering and other departments at the ÈËÆÞÖгöÊÓƵ of Utah, awarded grants to interdisciplinary research teams seeking innovative engineering solutions for cancer challenges.
Three new physician-scientists have been welcomed to The Society of Huntsman Translational Scholars, recognizing their groundbreaking work in translating cancer research into real-world innovations that improve patient care.
Two Huntsman Cancer Institute researchers are recognized with endowed chairs. Endowed chairs are created through philanthropy and honor accomplishments in research.
Sigma Chi International Fraternity announces $31 million pledge to create the Sigma Chi Center for Advanced Therapeutics and Innovation at Huntsman Cancer Institute, the largest pledge in the fraternity’s history.
New drug therapy gives hope to advanced melanoma patients, personalized exercise plans enhance lung cancer patient recovery, and patient receives first allogeneic stem cell transplant from a deceased organ donor.
Despite being proven to prevent six types of cancers, HPV vaccination rates remain low. An AI chatbot could help parents and caregivers better navigate HPV vaccination decisions.
A nationally recognized cancer surgeon and academic leader, Gamblin brings deep expertise in cancer care, research, and innovation to advance surgical oncology across the Mountain West.
With a focus on innovation and collaboration, Welm will lead efforts to advance the Department of Oncological Sciences’ academic mission and scientific excellence, while positioning the department for national distinction.
A novel clinical trial aims to help more patients with aggressive blood cancers access transplants—without the delays or limitations of traditional donor matching.
Could the future of prostate cancer rehabilitation be in virtual reality? A trial at Huntsman Cancer Institute explores how telerehabilitation can help rural and frontier patients.
